Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AlloMSC Transplantation for Refractory SLE
NCT00698191Phase 2Unknown
- Sponsor
- Nanjing Medical University
- Start
- Mar 2007
- Primary completion
- Dec 2011
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of allogeneic bone marrow-derived mesenchymal stem cells in systemic lupus erythematosus (SLE), lupus nephritis (LN), sponsored by Nanjing Medical University. Status: unknown.
02
Drugs
allogeneic bone marrow-derived mesenchymal stem cells
03
Conditions
systemic lupus erythematosus (SLE)lupus nephritis (LN)
Beyond the preview
Go deeper on NCT00698191.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00698191.